Citation: | LI Ye, YANG Ru-yi, LI Meng-qi, ZHANG Wen-jing, CHEN Fa-zhang. Clinical Study on Self-Made Fuzheng Jiedu Formula in Treating Cancer-Related Fatigue of Patients with Gastric Cancer after Chemotherapy[J]. Journal of Nanjing University of traditional Chinese Medicine, 2021, 37(3): 366-370. doi: 10.14148/j.issn.1672-0482.2021.0366 |
[1] |
谢晓冬, 张潇宇. 癌因性疲乏最新进展: NCCN(2018版)癌因性疲乏指南解读[J]. 中国肿瘤临床, 2018, 45(16): 817-820. doi: 10.3969/j.issn.1000-8179.2018.16.676
|
[2] |
DENLINGER CS, LIGIBEL JA, ARE M, et al. Survivorship: fatigue, version 1.2014[J]. J Natl Compr Canc Netw, 2014, 12(6): 876-887. doi: 10.6004/jnccn.2014.0082
|
[3] |
ZHAO YY, WANG SM, LI JH, et al. Effectiveness and safety of traditional Chinese medical therapy for cancer-related fatigue: A systematic review and Meta-analysis of randomized controlled trials[J]. Tradit Chin Med, 2020, 40(5): 738-748. http://www.ncbi.nlm.nih.gov/pubmed/33000574
|
[4] |
SANO T, COIT DG, KIM HH, et al. Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project[J]. Gastric Cancer, 2017, 20(2): 217-225. doi: 10.1007/s10120-016-0601-9
|
[5] |
胃癌规范化诊疗指南(试行)[J]. 慢性病学杂志, 2013, 14(8): 561-568.
|
[6] |
MENDOZA TR, WANG XS, CLEELAND CS, et al. The rapid assessment of fatigue severity in cancer patients: Use of the brief fatigue inventory[J]. Cancer, 1999, 85(5): 1186-1196. doi: 10.1002/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N
|
[7] |
OKUYAMA T, AKECHI T, KUGAYA A, et al. Development and validation of the cancer fatigue scale: A brief, three-dimensional, self-rating scale for assessment of fatigue in cancer patients[J]. J Pain Symptom Manage, 2000, 19(1): 5-14. doi: 10.1016/S0885-3924(99)00138-4
|
[8] |
张凤玲, 丁玥, 韩丽沙. 癌症疲乏量表中文版的信效度[J]. 中国心理卫生杂志, 2011, 25(11): 810-813. doi: 10.3969/j.issn.1000-6729.2011.11.003
|
[9] |
WANG XS, HAO XS, WANG Y, et al. Validation study of the Chinese version of the brief fatigue inventory (BFI-C)[J]. J Pain Symptom Manage, 2004, 27(4): 322-332. doi: 10.1016/j.jpainsymman.2003.09.008
|
[10] |
BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. doi: 10.3322/caac.21492
|
[11] |
FENG RM, ZONG YN, CAO SM, et al. Current cancer situation in China: Good or bad news from the 2018 Global CancerStatistics?[J]. Cancer Commun, 2019, 39(1): 22. doi: 10.1186/s40880-019-0368-6
|
[12] |
蔡成喜, 赵文琦. 青海省西宁市2009-2014年居民胃癌流行趋势分析[J]. 中华肿瘤防治杂志, 2018, 25(6): 381-383. https://www.cnki.com.cn/Article/CJFDTOTAL-QLZL201806001.htm
|
[13] |
林学英, 王云启. 中医药治疗癌因性疲乏的研究进展[J]. 中医药导报, 2016, 22(24): 37-40. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZB201624012.htm
|
[14] |
黄帝内经素问[M]. 北京: 人民卫生出版社, 2005: 57, 189.
|
[15] |
颜悦, 于晓宇, 郭姗琦, 等. 中医药治疗癌因性疲乏研究进展[J]. 天津中医药, 2019, 36(1): 96-100. https://www.cnki.com.cn/Article/CJFDTOTAL-TJZY201901025.htm
|
[16] |
江奋霞, 徐爱国, 张茜, 等. 贞芪扶正胶囊对晚期非小细胞肺癌患者免疫功能、生存质量、化疗不良反应的影响[J]. 现代中西医结合杂志, 2019, 28(35): 3926-3929. doi: 10.3969/j.issn.1008-8849.2019.35.013
|
[17] |
冯滢滢, 李军, 刘泉龙, 等. 贞芪扶正胶囊辅助大肠癌术后化疗临床观察[J]. 北京中医药, 2015, 34(10): 810-812. https://www.cnki.com.cn/Article/CJFDTOTAL-BJZO201510018.htm
|
[18] |
王海明, 任芳, 崔艺馨. 贞芪扶正胶囊减轻胃癌术后肿瘤复发疗效观察[J]. 山西医药杂志, 2015, 44(5): 560-562. https://www.cnki.com.cn/Article/CJFDTOTAL-SXYY201505032.htm
|
[19] |
程海波, 吴勉华. 周仲瑛教授"癌毒"学术思想探析[J]. 中华中医药杂志, 2010, 25(6): 866-869. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201006022.htm
|
[20] |
刘畅, 赵晓珍, 王中奇, 等. 肺岩宁方联合抗瘤增效方对中晚期肺腺癌患者化疗后癌因性疲乏、免疫功能及肿瘤标志物影响的临床研究[J]. 上海中医药杂志, 2019, 53(6): 49-53. https://www.cnki.com.cn/Article/CJFDTOTAL-SHZZ201906016.htm
|
[21] |
殷霞, 余敏华, 张义, 等. CD4、CD8、FoxP3在子宫颈癌新辅助化疗前后表达的变化及临床价值[J]. 实用妇产科杂志, 2019, 35(10): 750-755. https://www.cnki.com.cn/Article/CJFDTOTAL-SFCZ201910013.htm
|
[22] |
王春霞, 辛丽亚, 张桂红. 肺癌患者化疗前后外周血T淋巴细胞亚群及NK细胞的变化[J]. 中华肿瘤防治杂志, 2018, 25(S2): 48-49. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX201235005.htm
|
[23] |
谢兴凤, 张旭. 肿瘤标志物CA724在肿瘤中的研究进展[J]. 检验医学与临床, 2020, 17(19): 2896-2898. doi: 10.3969/j.issn.1672-9455.2020.19.047
|
[24] |
杨莉, 李晓南, 杨晓雪. 血清肿瘤标志物CEA、CA19-9及CA724联合检测在胃癌诊断中的价值分析[J]. 临床和实验医学杂志, 2020, 19(4): 387-391. doi: 10.3969/j.issn.1671-4695.2020.04.015
|
[25] |
于冬建. 红景天药理学研究及临床作用新进展[J]. 中医临床研究, 2020, 12(18): 136-138. doi: 10.3969/j.issn.1674-7860.2020.18.053
|
[26] |
黄薇, 荣黎, 陈耀凯, 等. 红景天甙对人胃癌细胞增殖及凋亡影响的研究[J]. 中国免疫学杂志, 2019, 35(6): 676-679, 685. doi: 10.3969/j.issn.1000-484X.2019.06.007
|
[27] |
吴琳华, 郭劲柏, 刘红梅, 等. 仙鹤草注射液对人癌细胞生长抑制作用的研究[J]. 中国中医药科技, 2005, 12(5): 297-298. doi: 10.3969/j.issn.1005-7072.2005.05.015
|
[28] |
杜洋, 邵淑丽, 焦凯贺, 等. 白花蛇舌草对人胃癌细胞MNK-45线粒体膜电位及凋亡相关基因表达的影响[J]. 中国应用生理学杂志, 2020, 36(2): 171-175. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGSL202002017.htm
|